(Q34982546)

5 August 2017

title

Glutamate and its role in psychiatric illness (English)

1 reference

5 August 2017

Brendan Belsham

1

1 reference

5 August 2017

language of work or name

1 reference

1 March 2001

1 reference

5 August 2017

published in

Human Psychopharmacology

1 reference

5 August 2017

volume

16

1 reference

5 August 2017

issue

2

1 reference

5 August 2017

page(s)

139-146

1 reference

Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia.

5 August 2017

cites work

1 reference

Deficits in Small Interneurons in Prefrontal and Cingulate Cortices of Schizophrenic and Schizoaffective Patients

21 January 2018

1 reference

Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging.

21 January 2018

1 reference

Neuroexcitatory plasma amino acids are elevated in migraine.

21 January 2018

1 reference

The dopamine hypothesis: an overview of studies with schizophrenic patients

21 January 2018

1 reference

Recent advances in the phencyclidine model of schizophrenia

21 January 2018

1 reference

Adult schizophrenia following prenatal exposure to an influenza epidemic

21 January 2018

1 reference

Glutamate receptor dysfunction and schizophrenia

21 January 2018

1 reference

Effect of clozapine and adjunctive high-dose glycine in treatment-resistant schizophrenia.

21 January 2018

1 reference

Limbic System Abnormalities Identified in Schizophrenia Using Positron Emission Tomography With Fluorodeoxyglucose and Neocortical Alterations With Deficit Syndrome

21 January 2018

1 reference

Abnormal excitatory neurotransmitter metabolism in schizophrenic brains

21 January 2018

1 reference

Excitatory amino acid receptors in schizophrenia

21 January 2018

1 reference

The glutamatergic basis of human alcoholism

21 January 2018

1 reference

Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine.

21 January 2018

1 reference

7 January 2021

Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics

1 reference

7 January 2021

Measles virus-induced hippocampal neurodegeneration in the mouse: a novel, subacute model for testing neuroprotective agents

1 reference

7 January 2021

Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging.

1 reference

7 January 2021

The specificity of platelet glutamate receptor supersensitivity in psychotic disorders

1 reference

7 January 2021

Supersensitive platelet glutamate receptors as a possible peripheral marker in schizophrenia

1 reference

7 January 2021

Acute application of the tricyclic antidepressant desipramine presynaptically stimulates the exocytosis of glutamate in the hippocampus

1 reference

7 January 2021

A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

1 reference

7 January 2021

The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice

1 reference

7 January 2021

Differential modulation by dopamine of responses evoked by excitatory amino acids in human cortex

1 reference

7 January 2021

Lack of evidence for close linkage of the glutamate GluR6 receptor gene with schizophrenia

1 reference

7 January 2021

Clozapine treatment increases serum glutamate and aspartate compared to conventional neuroleptics

1 reference

7 January 2021

Placebo-controlled trial of glycine added to clozapine in schizophrenia

1 reference

7 January 2021

Glycine agonists: what can they teach us about schizophrenia?

1 reference

7 January 2021

Prenatal ethanol exposure decreases hippocampal 3H-glutamate binding in 45-day-old rats

1 reference

7 January 2021

Molecular Neurobiology of Glutamate Receptors

1 reference

7 January 2021

D-cycloserine added to clozapine for patients with schizophrenia

1 reference

7 January 2021

A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia

1 reference

7 January 2021

Decreased hippocampal expression of a glutamate receptor gene in schizophrenia

1 reference

7 January 2021

Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia.

1 reference

7 January 2021

Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia

1 reference

7 January 2021

NMDA glutamatergic receptors, labelled with [3H]MK-801, in brain samples from drug-free depressed suicides

1 reference

7 January 2021

Hypobaric-ischemic conditions produce glutamate-like cytopathology in infant rat brain.

1 reference

7 January 2021

Plasma glutamate decarboxylase activity in neuropsychiatry

1 reference

7 January 2021

The olfactory bulbectomized rat as a model of depression: an update

1 reference

7 January 2021

Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem

1 reference

7 January 2021

Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

1 reference

7 January 2021

Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes

1 reference

7 January 2021

Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy.

1 reference

7 January 2021

Ketamine activates psychosis and alters limbic blood flow in schizophrenia.

1 reference

7 January 2021

Excitatory amino acids as a final common pathway for neurologic disorders.

1 reference

7 January 2021

Serum levels of excitatory amino acids, serine, glycine, histidine, threonine, taurine, alanine and arginine in treatment-resistant depression: modulation by treatment with antidepressants and prediction of clinical responsivity.

1 reference

7 January 2021

Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment

1 reference

7 January 2021

Neurotoxicity of N-methyl-D-aspartate is markedly enhanced in developing rat central nervous system

1 reference

7 January 2021

Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.

1 reference

7 January 2021

Piracetam in the treatment of schizophrenia: implications for the glutamate hypothesis of schizophrenia

1 reference

7 January 2021

Adaptation of cortical but not hippocampal NMDA receptors after chronic citalopram treatment

1 reference

7 January 2021

Glycine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label, pilot study.

1 reference

7 January 2021

Activation of dopamine receptors inhibits calcium-dependent glutamate release from cortico--striatal terminals in vitro

1 reference

7 January 2021

The role of 5-HT2A receptors in antipsychotic activity

1 reference

7 January 2021

Excitatory amino acids: implications for psychiatric disorders research

1 reference

7 January 2021

Functional antagonists at the NMDA receptor complex exhibit antidepressant actions

1 reference

7 January 2021

Efficacy and tolerance of D-cycloserine in drug-free schizophrenic patients

1 reference

7 January 2021

Glycine therapy of schizophrenia

1 reference

7 January 2021

Autoradiographic characterization of neurotensin receptors in the entorhinal cortex of schizophrenic patients and control subjects

1 reference

7 January 2021

Proton magnetic resonance spectroscopy of the temporal lobes in schizophrenics and normal controls.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.279

1 reference

release_g64n4i5f5bchzkfwpuwp5oolgi

5 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/g64n4i5f5bchzkfwpuwp5oolgi

24 November 2022

mapped directly with Wikidata item

1 reference